首页> 外文期刊>Journal of Pain Research >EDsub50/sub of intrathecal ropivacaine for cesarean delivery with and without epidural volume extension with normal saline: a randomized controlled study.
【24h】

EDsub50/sub of intrathecal ropivacaine for cesarean delivery with and without epidural volume extension with normal saline: a randomized controlled study.

机译:鞘内罗哌卡因的ED 50 用于在有或没有硬膜外扩容的情况下用生理盐水进行剖宫产的随机对照研究。

获取原文
           

摘要

Background: It was reported that epidural volume extension could decrease the ED50 of intrathecal plain bupivacaine. In this study, we investigated the ED50 of intrathecal hyperbaric ropivacaine followed by epidural normal saline bolus for cesarean section. Methods: Sixty parturients were allocated into two groups in this prospective study. About 10?mL of epidural normal saline was given after the intrathecal dose of hyperbaric ropivacaine in the Group S (normal saline group), and no epidural injection of normal saline was given after the intrathecal ropivacainve injection in the Group C (control group). The dose of intrathecal ropivacaine for each parturient was decided by up-down allocation method. The initial dose was set as 10 mg. Effective anesthesia was defined as the level of T6 or above achieved within 10 minutes after intrathecal injection and no additional epidural drug to complete operation. The Massey formula was applied to calculate the ED50 of intrathecal ropivacaine. Results: The ED50 of intrathecal ropivacaine for cesarean section determined by up-and-down method was 7.51 mg (95% CI, 7.09–7.93 mg) in the Group S and 8.29 mg (95% CI, 7.73–8.85 mg) in the Group C, and there was a significant difference in ED50 of ropivacaine between the two groups ( P 0.05). Compared with the Group C, the ED50 of intrathecal ropivacaine decreased when followed by epidural normal saline bolus. Conclusion: The ED50 of intrathecal hyperbaric ropivacaine for cesarean section is 8.29 mg, and it is reduced when followed by epidural normal saline bolus (www.chictr.org.cn, registration number: ChiCTR-ROC-17013382).
机译:背景:据报道,硬膜外扩容可降低鞘内平原布比卡因的ED50。在这项研究中,我们调查了鞘内高压罗哌卡因后硬膜外生理盐水推注剖宫产的ED50。方法:在这项前瞻性研究中,将60名产妇分为两组。 S组(生理盐水组)鞘内注射高压罗哌卡因后,给予约10?mL硬膜外生理盐水; C组(对照组)鞘内注射罗哌卡因后,不给予硬膜外注射生理盐水。通过上下分配方法确定每个产妇的鞘内罗哌卡因剂量。初始剂量设定为10 mg。有效麻醉的定义是鞘内注射后10分钟内达到T6或更高水平,并且没有其他硬膜外药物来完成手术。应用Massey公式计算鞘内罗哌卡因的ED50。结果:通过上下法确定的剖宫产鞘内罗哌卡因的ED50为S组为7.51 mg(95%CI,7.09–7.93 mg),S组为8.29 mg(95%CI,7.73–8.85 mg)。 C组,罗哌卡因的ED50在两组之间有显着差异(P <0.05)。与硬膜外正常生理盐水推注相比,鞘内罗哌卡因的ED50降低。结论:鞘内高压罗哌卡因用于剖宫产的ED50为8.29 mg,并在硬膜外给予生理盐水推注后降低(www.chictr.org.cn,注册号:ChiCTR-ROC-17013382)。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号